Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 433

1.

Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.

Li D, Zhang Y, Liu Y, Sun R, Xia M.

J Nutr. 2015 Apr;145(4):742-8. doi: 10.3945/jn.114.205674. Epub 2015 Feb 4.

PMID:
25833778
2.

Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.

Guardiola M, Plana N, Ibarretxe D, Cabré A, González M, Ribalta J, Masana L.

Clin Sci (Lond). 2015 Jun;128(12):877-82. doi: 10.1042/CS20140832.

PMID:
25649668
3.

[Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia--what benefits do we gain compared with cholesterol measurements?].

Leiviskä J, Sundvall J, Jauhiainen M, Laatikainen T.

Duodecim. 2014;130(22-23):2331-7. Finnish.

PMID:
25558595
4.

Statin-induced diabetes: how important is insulin resistance?

Abbasi F, Reaven GM.

J Intern Med. 2015 Apr;277(4):498-500. doi: 10.1111/joim.12297. Epub 2014 Sep 25. No abstract available.

PMID:
25156816
5.

Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.

Banin RM, Hirata BK, Andrade IS, Zemdegs JC, Clemente AP, Dornellas AP, Boldarine VT, Estadella D, Albuquerque KT, Oyama LM, Ribeiro EB, Telles MM.

Braz J Med Biol Res. 2014 Sep;47(9):780-8. Epub 2014 Jul 25.

6.

A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents.

Gidding SS, Prospero C, Hossain J, Zappalla F, Balagopal PB, Falkner B, Kwiterovich P.

J Pediatr. 2014 Sep;165(3):497-503.e2. doi: 10.1016/j.jpeds.2014.05.039. Epub 2014 Jul 7.

PMID:
25008950
7.

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL; SMART Study Group.

PLoS One. 2014 Jun 30;9(6):e101082. doi: 10.1371/journal.pone.0101082. eCollection 2014.

8.

Preventive effects of jujube polysaccharides on fructose-induced insulin resistance and dyslipidemia in mice.

Zhao Y, Yang X, Ren D, Wang D, Xuan Y.

Food Funct. 2014 Aug;5(8):1771-8. doi: 10.1039/c3fo60707k.

PMID:
24906476
9.

Habitual physical activity and cardiometabolic risk factors in adults with cerebral palsy.

Ryan JM, Crowley VE, Hensey O, Broderick JM, McGahey A, Gormley J.

Res Dev Disabil. 2014 Sep;35(9):1995-2002. doi: 10.1016/j.ridd.2014.03.051. Epub 2014 May 24.

10.
11.

Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.

Ohno Y, Miyoshi T, Noda Y, Oe H, Toh N, Nakamura K, Kohno K, Morita H, Ito H.

Cardiovasc Diabetol. 2014 Apr 5;13:71. doi: 10.1186/1475-2840-13-71.

12.

Postprandial lipemia as a cardiometabolic risk factor.

Pirillo A, Norata GD, Catapano AL.

Curr Med Res Opin. 2014 Aug;30(8):1489-503. doi: 10.1185/03007995.2014.909394. Epub 2014 May 2. Review.

PMID:
24673475
13.

Combined dyslipidemia in obese children: response to a focused lifestyle approach.

Pratt RE, Kavey RE, Quinzi D.

J Clin Lipidol. 2014 Mar-Apr;8(2):181-6. doi: 10.1016/j.jacl.2014.01.003. Epub 2014 Jan 19.

PMID:
24636177
14.

Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients.

Pineda-Tenor D, Berenguer J, García-Broncano P, Jiménez-Sousa MA, Fernández-Rodríguez A, Diez C, García-Álvarez M, Carrero A, Catalán P, Aldámiz-Echevarria T, Resino S.

Eur J Clin Invest. 2014 May;44(5):453-62. doi: 10.1111/eci.12250. Epub 2014 Mar 7.

PMID:
24528335
15.

Postprandial hypertriglyceridemia as a coronary risk factor.

Borén J, Matikainen N, Adiels M, Taskinen MR.

Clin Chim Acta. 2014 Apr 20;431:131-42. doi: 10.1016/j.cca.2014.01.015. Epub 2014 Feb 6. Review.

PMID:
24508990
16.

Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets.

Ng DS.

Can J Diabetes. 2013 Oct;37(5):319-26. doi: 10.1016/j.jcjd.2013.07.062. Review.

PMID:
24500559
17.

Postprandial effects of long-term niacin/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome.

Aye MM, Kilpatrick ES, Afolabi P, Wootton SA, Rigby AS, Coady AM, Sandeman DD, Atkin SL.

Diabetes Obes Metab. 2014 Jun;16(6):545-52. doi: 10.1111/dom.12255. Epub 2014 Feb 9.

PMID:
24401089
18.

Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial.

Annuzzi G, Bozzetto L, Costabile G, Giacco R, Mangione A, Anniballi G, Vitale M, Vetrani C, Cipriano P, Della Corte G, Pasanisi F, Riccardi G, Rivellese AA.

Am J Clin Nutr. 2014 Mar;99(3):463-71. doi: 10.3945/ajcn.113.073445. Epub 2013 Dec 24.

19.

Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.

Ng TW, Ooi EM, Watts GF, Chan DC, Barrett PH.

Diabetes Obes Metab. 2014 Jun;16(6):519-26. doi: 10.1111/dom.12243. Epub 2013 Dec 29.

PMID:
24299019
20.

[Pathogenic mechanisms of proatherogenic changes in pregnant women with concomitant obesity].

Tarasenko KV, Mamontova TV.

Lik Sprava. 2013 Dec;(8):37-43. Ukrainian.

PMID:
25726675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk